| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 05/27/2004 | US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 05/27/2004 | US20040101523 Blocking biosynthesis of neurotransmitters; enzyme inhibitors; cardiovascular disorders |
| 05/26/2004 | EP1022272B1 Substituted fused heterocyclic compounds |
| 05/26/2004 | CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/25/2004 | US6740654 Inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders, or disorders involving the inappropriate growth or migration of cells. |
| 05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| 05/21/2004 | WO2004041273A1 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3-SULFONYL]-PYRROLIDINE-2-CARBOXYLIC ACID AMIDE AS ANTI-INFLAMMATORY AGENTS |
| 05/21/2004 | WO2004041209A2 Transcription factor modulating compounds and methods of use thereof |
| 05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 05/21/2004 | CA2504131A1 Derivatives of [6,7-dihydro-5h-imidazo[1,2-alpha]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide as anti-inflammatory agents |
| 05/20/2004 | US20040097594 Sulfonamide inhibitors of aspartyl protease |
| 05/20/2004 | US20040097570 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
| 05/19/2004 | EP1418923A1 Anti-bacterial agents based upon oxoanion binding |
| 05/19/2004 | EP1418915A1 Neuroprotective drug |
| 05/19/2004 | EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 05/19/2004 | EP1131308B1 New piperazine and piperidine compounds |
| 05/19/2004 | CN1498214A Bicyclic guanidine derivatives and therapeutic uses thereof |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1150281C Azo compounds and process for preparing the same |
| 05/18/2004 | US6737432 Crystalline form of telmisartan sodium |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/18/2004 | US6737415 Anti-bacterial agents based upon oxoanion binding |
| 05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
| 05/13/2004 | US20040092556 Aids therapy |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/12/2004 | EP1417178A2 Heterocyclic amide derivatives and the use thereof as pesticides |
| 05/12/2004 | EP1218352B1 Benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity |
| 05/12/2004 | EP1028111B1 Amide derivatives or salts thereof |
| 05/12/2004 | EP1015429B1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 05/12/2004 | CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation |
| 05/12/2004 | CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance |
| 05/12/2004 | CN1494829A Antimicrobial additive and ink composition containing said additive |
| 05/12/2004 | CN1149201C Novel spiro imidazoline compounds, their prepn. method and medicinal compsns. containing same |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734149 Thiohydantoin derivative, dithiophosphate |
| 05/11/2004 | US6733905 Metal coordination compound, luminescence device and display apparatus |
| 05/06/2004 | WO2004037251A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/06/2004 | WO2003105779A3 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 05/06/2004 | US20040087801 Renin inhibitors; congesitive heart failure; glaucoma |
| 05/06/2004 | US20040087798 Novel amide compounds |
| 05/06/2004 | US20040087620 Terphenyl compounds bearing substituted amino groups |
| 05/06/2004 | US20040087599 cGMP-PDE inhibitors for the treatment of erectile dysfunction |
| 05/06/2004 | US20040087595 1-aryl- or 1-alkylsulfony-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | EP1414816A1 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
| 05/06/2004 | EP1414795A1 Bicyclic modulators of androgen receptor function |
| 05/06/2004 | EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 05/06/2004 | CA2501228A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/05/2004 | CN1494423A Benzimidazole derivatives as therapeutic agents |
| 05/04/2004 | US6730796 Process for preparation of N-substituted 2-sulfanylimidazoles |
| 05/04/2004 | US6730795 Reacting o-phenylene-diamine with terephthalic acid and chlorosulfonic acid in the presence of strong acids to produce phenylene-bis-benzimidazole- tetrasulfonic acid di-sodium salt |
| 05/04/2004 | US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 04/29/2004 | WO2004035549A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 04/29/2004 | WO2004035548A1 Novel compounds |
| 04/29/2004 | WO2004035534A2 Novel compounds having a dopaminergic and/or serotoninergic activity |
| 04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/29/2004 | WO2004016086A3 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 04/29/2004 | WO2003099823A3 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 04/29/2004 | US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/29/2004 | US20040082637 Heterocyclic topoisomerase poisons |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082583 Chemical compounds |
| 04/29/2004 | US20040082571 Substituted piperazines |
| 04/29/2004 | US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin |
| 04/29/2004 | US20040082496 For the treatment of body weight disorders (obesity/anorexia/ bulemia/cachexia) |
| 04/29/2004 | DE10248925A1 Neue Verbindungen mit dopaminerger und/oder serotoninerger Aktivität New connections with dopaminergic and / or serotonergic activity |
| 04/29/2004 | CA2501539A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 04/29/2004 | CA2501418A1 Novel compounds |
| 04/29/2004 | CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/28/2004 | EP1411928A1 Viral polymerase inhibitors |
| 04/28/2004 | EP0881267B1 Azo compounds and process for preparing the same |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727041 Optical recording media |
| 04/22/2004 | WO2004033426A2 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents |
| 04/22/2004 | WO2004032861A2 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | US20040077642 Pyrimidine compounds |
| 04/22/2004 | US20040077634 Treatment of diseases characterized by excessive or insufficient cell death |
| 04/22/2004 | US20040077619 Calcium receptor modulating agents |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1408963A1 2- 5-(5-CARBAMIMIDOYL-1 i H /i -HETEROARYL)-6-HYDROXYBIPHENYL-3-YL]-SUCCINIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS |
| 04/21/2004 | EP0973750B1 Substituted benzimidazoles and their use for treating retroviral infection |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491226A Epindolidione pigments |
| 04/21/2004 | CN1491220A Lactone compound as novel photoinitiators |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1146566C 2-aryl-8-oxodihydropurine derivatives, process for producing same, medicinal conty, same, and intermediates thereof |
| 04/21/2004 | CN1146539C Process for preparing sparingly soluble aromatic amines |
| 04/21/2004 | CN1146416C Use of H+, K+-ATPase inhibitor in treatment of nasal polyps |
| 04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |